A large genetic study published in Nature Genetics has found that early- and late-onset depression represent biologically distinct conditions, with meaningful differences in genetic architecture, clinical features, and risk profiles. The findings could guide more targeted diagnostic and therapeutic approaches for major depressive disorder (MDD), one of the world’s leading causes of disability.
Distinct Genetic Profiles
Using genome-wide association studies (GWAS), researchers analyzed genetic data from more than 80,000 individuals diagnosed with MDD across Nordic biobanks. The study identified 12 genomic loci and 17 significant genes linked to early-onset depression, compared to only two loci and four genes for late-onset cases. Heritability was nearly twice as high for early-onset MDD (11.2 percent) than for late-onset (6 percent), suggesting that early cases have stronger genetic underpinnings involving fewer, higher-impact variants.
Divergent Clinical and Biological Traits
Early-onset depression, which typically arises in adolescence or young adulthood, correlated with genes involved in neurodevelopment and was strongly linked to psychotic symptoms, suicide attempts, and other psychiatric disorders such as schizophrenia and autism spectrum disorder. In contrast, late-onset depression, which often develops after midlife, showed associations with reduced cognitive performance and increased cardiovascular risk.
Both subtypes demonstrated moderate genetic overlap but differed in how their loci related to external traits. Genetic links between early-onset MDD and suicide attempts were more than twice as strong as those for late-onset depression. Researchers also found shared, though weaker, associations between late-onset MDD and health traits such as suicide death or heart failure.
Polygenic Risk and Suicide Prediction
The study’s polygenic risk score (PRS) analysis indicated that individuals in the top 10 percent of early-onset MDD PRS faced a 26 percent risk of suicide attempts within ten years of diagnosis, compared to 12 percent for those in the lowest decile. These differences became evident about five years after diagnosis. The results underscore the potential of genetic screening tools to identify younger patients at highest risk for suicidal behavior.
Implications for Clinical Practice
By reducing genetic and clinical heterogeneity, the study demonstrates that distinguishing between depression subtypes can yield clearer biological signals. Researchers suggest that a similar stratified approach—focusing on specific symptom patterns like psychosis or vegetative features—could refine understanding of depression’s many forms. This precision could eventually inform personalized prevention and treatment strategies for patients with different onset patterns of major depression.
Related topics
